EUVIMEDEUVIMED entdecken
Kohortenstudie

Prognostic value of MIB-1 index in meningioma: a retrospective cohort study to establish an optimal cutoff for recurrence and survival

Ishav Y Shukla, Ali Ebada, Nicholas Bever, Jeffrey I Traylor, Bingchun Wan, Darsh Shah, Samuel L Barnett, Matthew Z Sun

Journal of Neuro-Oncology · 2025

DOI: 10.1007/s11060-025-05057-2 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Neuro-Oncology, 2025. Verfasst von Ishav Y Shukla und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA. Hauptthemen laut MEDLINE: Meningioma, Meningeal Neoplasms, Neoplasm Recurrence, Local, Ki-67 Antigen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Predicting long-term outcomes after meningioma resection remains challenging. Ki-67/MIB-1 correlates with recurrence, yet its optimal cutoff is undefined. This study aims to establish a threshold that enhances risk stratification, improves recurrence prediction, and informs postoperative surveillance and adjuvant treatment strategies. METHODS: This is retrospective study of patients who underwent meningioma resection. Receiver operating characteristic (ROC) analysis determined the optimal MIB-1 cutoff for predicting recurrence and survival, providing area under the curve (AUC). This cutoff was then applied in Kaplan-Meier survival analyses and multivariable Cox regressions, controlling for age, sex, tumor diameter, tumor location, extent of resection, and adjuvant radiotherapy. RESULTS: A total of 404 patients were included. Median age was 55.0 years (range: 16-85) and 72.3% were female. The cohort primarily consisted of WHO Grade 1 (69.6%) and Grade 2 (30.0%) meningiomas. An optimal MIB-1 index cutoff of 4.1% was identified using ROC analysis with the Youden index for predicting recurrence (AUC = 0.661, p < 0.001) and survival (AUC = 0.717, p < 0.001). 241 patients (59.7%) had a MIB-1 < 4.1%, and 163 (40.3%) had a MIB-1 ≥ 4.1%. Patients with MIB-1 ≥ 4.1% had a higher risk of recurrence (HR = 2.9, p = 0.009) and mortality (HR = 2.8, p = 0.036). Patients with MIB-1 ≥ 4.1% demonstrated shorter recurrence-free survival (RFS) (119.0 vs. 129.0 months, p < 0.001) and overall survival (OS) (163.0 vs. 229.0 months, p < 0.001). CONCLUSION: We identified an optimal and actionable MIB-1 index cutoff of 4.1% which independently predicted recurrence, mortality, and shorter RFS and OS for patients undergoing meningioma resection. As the first study to establish and validate this threshold, our findings highlight its potential as an adjunct prognostic tool to refine risk stratification and guide postoperative management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MeningiomaMeningeal NeoplasmsNeoplasm Recurrence, LocalKi-67 AntigenHumansFemaleMaleMiddle AgedRetrospective StudiesAgedAdultAged, 80 and overPrognosisYoung AdultAdolescentROC CurveBiomarkers, TumorFollow-Up StudiesSurvival RateKaplan-Meier Estimate

Stichwörter der Autor:innen

BiomarkerMIB-1MeningiomaPrognosisRecurrenceSurvival

Substanzen

Ki-67 AntigenBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Neurological Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Department of Neurological Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA. Matthew.Sun@UTSouthwestern.edu.

Zitieren

APA

Shukla, I. Y., Ebada, A., Bever, N., Traylor, J. I., Wan, B., Shah, D., Barnett, S. L., & Sun, M. Z. (2025). Prognostic value of MIB-1 index in meningioma: a retrospective cohort study to establish an optimal cutoff for recurrence and survival. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-025-05057-2

Vancouver

Shukla IY, Ebada A, Bever N, Traylor JI, Wan B, Shah D, et al. Prognostic value of MIB-1 index in meningioma: a retrospective cohort study to establish an optimal cutoff for recurrence and survival. Journal of Neuro-Oncology. 2025. doi:10.1007/s11060-025-05057-2

BibTeX
@article{Shukla2025,
  author = {Shukla, Ishav Y and Ebada, Ali and Bever, Nicholas and Traylor, Jeffrey I and Wan, Bingchun and Shah, Darsh and Barnett, Samuel L and Sun, Matthew Z},
  title = {Prognostic value of MIB-1 index in meningioma: a retrospective cohort study to establish an optimal cutoff for recurrence and survival},
  journal = {Journal of Neuro-Oncology},
  year = {2025},
  doi = {10.1007/s11060-025-05057-2}
}
Kostenlos starten →